Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/118779
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | A platform for selective immuno-capture of cancer cells from urine |
Author: | Macgregor-Ramiasa, M. McNicholas, K. Ostrikov, K. Li, J. Michael, M. Gleadle, J.M. Vasilev, K. |
Citation: | Biosensors and Bioelectronics, 2017; 96:373-380 |
Publisher: | Elsevier |
Issue Date: | 2017 |
ISSN: | 0956-5663 1873-4235 |
Statement of Responsibility: | Melanie Macgregor-Ramiasa, Kym McNicholas, Kola Ostrikov, Jordan Li, Michael Michael, Jonathan M. Gleadle, Krasimir Vasilev |
Abstract: | Urothelial cancers are amongst the 10 most common types of cancer and represent a major health problem worldwide. Current urinary diagnostic tests for urothelial cancer are expensive and have limited sensitivity and specificity. In this work, proofs of concept for a selective cancer cell capture platform are presented with the aim to achieve the first generation of specific urinary tests for the detection of cancer cells in urine specimen. The unique reactivity of plasma deposited polyoxazoline was used to covalently bind cancer specific antibodies in microchannels. Cancer cells dispersed in patient urine were successfully captured with up to 99% selectivity and 100% sensitivity over a wide range of cell concentrations. The streamlined two steps preparation process of the capture platform represents an important advance in medical diagnostics, with broader potential applications. |
Keywords: | Polyoxazolines; plasma polymers; cancer cell capture; urine; diagnostic devices |
Rights: | © 2017 Elsevier B.V. All rights reserved. |
DOI: | 10.1016/j.bios.2017.02.011 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1122825 |
Published version: | http://dx.doi.org/10.1016/j.bios.2017.02.011 |
Appears in Collections: | Aurora harvest 8 Chemistry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.